Ozempic price in India

Dr Akash Shah
Medically reviewed by Dr Akash Shah · Written by PharmEasy Medical Team · Published on 21 August 2026 | Updated on 21 August 2026

Ozempic is available in India with MRPs starting at approximately ₹5,660 for the 0.25 mg starter pen.1

After the April 2026 price revision, a month's treatment plan will typically cost around ₹5,660 to ₹9,100, depending on the strength your doctor prescribes.3 However, the actual selling prices may be lower than the MRP, so always check the latest price before purchasing.

Prescription required. Ozempic is available only with a valid doctor's prescription. The dose and treatment plan are determined by your doctor.

MRP at a glance
0.25 mg pen₹5,660
0.5 mg pen₹8,100
1 mg pen₹9,100
Consult a doctor

GLP-1 medicines are prescription-only. A doctor can tell you whether one is appropriate for you and at what dose.

Consult a doctor Or take the eligibility self-check

The prices on this page are the Maximum Retail Prices (MRPs) listed on PharmEasy as of August 2026.1 MRP is the maximum retail price, and the actual selling price may be at or below the MRP. So, please check the latest price on the product page before ordering, as they may change over time.

Ozempic price by strength

Strength Pack/form MRP (₹) Order (prescription required)
Ozempic 0.25 mgPre-filled pen · 0.25 mg/0.19 ml (1.5 ml)₹5,660View 0.25 mg pen
Ozempic 0.5 mgPre-filled pen · 0.5 mg/0.37 ml (1.5 ml)₹8,100View 0.5 mg pen
Ozempic 1 mgPre-filled pen · 1 mg/0.74 ml (3 ml)₹9,100View 1 mg pen

The 0.25 mg pen is the usual starting dose. Your doctor will increase the dose gradually over time if needed, so your monthly treatment cost may change as your prescribed strength changes (see Ozempic dosage). That is why we provide a price range rather than a single monthly figure.

Want the monthly figure for the dose you have been prescribed? The calculator does the arithmetic. Cost calculator

What a month of Ozempic costs

Ozempic is a once-weekly injection, so a month is about four doses. Each pre-filled pen is a multi-dose pen designed to deliver several weekly doses at its labelled strength. Typically, the 0.5 mg and 1 mg pens are meant to deliver 4 doses, whereas the 0.25 mg pen is meant to deliver 6 doses of Ozempic.

Starting month (0.25 mg)

Around ₹5,660 at MRP for the starter pen, discounts may further reduce the cost. The pen is used to deliver 4 doses of 0.25 mg and 2 doses of 0.5 mg Ozempic.

As you titrate upward

Monthly spend rises with strength, into roughly the ₹5,660 to ₹9,100 at MRP range noted after the April 2026 price revision.

Note: Your actual monthly cost depends on your prescribed dose, the pen supplied, and the current selling price. The figures above are intended as a general guide rather than a quotation. Our GLP-1 cost calculator will help you estimate your monthly and annual treatment costs based on your prescribed dose.

Why Ozempic got cheaper in 2026

Several factors contributed to lower Ozempic prices in India during 2026. These include:

Dec 2025

Official launch in India: Ozempic was officially launched in India on 12 December 2025.4 Before then, it was available mainly through named-patient import routes, which were generally more expensive and less predictable. The official launch brought regular supply and transparent pricing.

Apr 2026

April 2026 price revision: Novo Nordisk revised Ozempic's pricing in April 2026,2 reducing the MRP across strengths. As a result, the monthly treatment cost now typically ranges from approximately ₹5,660 to ₹9,100 (depending on the prescribed strength).

Mar 2026

Greater market competition: Following the expiry of the semaglutide patent in India on 20 March 2026, multiple generic semaglutide brands have entered the market.5 This increased competition may have contributed to greater price competition across the semaglutide category.

Note: It is also important to remember that pricing and regulatory approval are separate issues. Although the market has changed, Ozempic remains approved in India only for the management of type 2 diabetes.

Generic semaglutide options in India

Following the expiry of the semaglutide patent in India in March 2026, more than 25 generic semaglutide brands entered the market. Some are available at substantially lower prices than branded products, with prices starting from around ₹350 per week.7 PharmEasy lists several of these brands, including Semalix, Semanat, Semasize, Sundae, Glipiq, Poviztra and Bluvial, among others.

When comparing options, keep these points in mind:

They contain the same active ingredient (semaglutide) but may differ in brand, strength, dosage form (injection or tablet), supporting clinical data and approved indication.6 All are Schedule H prescription medicines.

Approved uses vary by brand. Some semaglutide products are approved for type 2 diabetes, while others are approved for chronic weight management. A lower-priced product is not necessarily a substitute for Ozempic, so any change in treatment should be made only on your doctor's advice.

Compare products carefully. See our semaglutide molecule page for the latest brands, strengths, approved indications, and prices.

If you are looking for oral semaglutide, Rybelsus is the once-daily tablet approved in India for type 2 diabetes. If your goal is chronic weight management, the approved semaglutide brand is Wegovy. Check our Wegovy price page for more details. However, all these decisions should be made under the guidance of a doctor.

Cheaper is not automatically comparable - approved use and dosing differ between brands. Compare all brands

Does insurance cover Ozempic?

In India, most standard health insurance policies are designed primarily to cover hospitalisation expenses. As a result, when prescribed on outpatient (OPD) basis, Ozempic may not be covered unless your policy includes OPD benefits, pharmacy cover, or a chronic disease management benefit.

Note: Since Ozempic is prescribed for type 2 diabetes, coverage may be available under some employer-sponsored or comprehensive health insurance plans, but this strictly varies by insurer and policy.

Always check your policy documents or contact your insurer to confirm whether prescribed diabetes medicines and outpatient pharmacy expenses are covered. Keep your doctor's prescription and pharmacy invoice, as these may be required if you submit a claim.

How to buy Ozempic with a prescription

Ozempic is a Schedule H prescription medicine and cannot be purchased over the counter. One must follow the steps when you are considering treatment with Ozempic:

1
Consult a doctor

Your doctor will determine whether Ozempic is appropriate for you and prescribe the correct strength and dose-escalation plan if suitable. According to the DCGI's March 2026 guidance, GLP-1 medicines should be prescribed by specialists such as endocrinologists, internal-medicine physicians or cardiologists.5

2
Obtain a valid prescription

Use Ozempic only under medical supervision and follow the treatment plan recommended by your doctor.

3
Order from a licensed pharmacy (like PharmEasy)

Upload your prescription when placing your order. Your prescription will be verified before the medicine is dispensed.

Note: Buy only from licensed pharmacies using a valid prescription. Since counterfeit GLP-1 medicines have been reported in India, it is important to always check the packaging, batch number, expiry date, and seal before use. If you already have a valid prescription, you can view Ozempic on PharmEasy. A valid prescription is required. We ship only 100% genuine, cold-chain-shipped medicines from licensed pharmacies.

Before you book a consultation, the self-check shows the criteria a doctor generally considers. Am I eligible?

FAQs

What is the price of Ozempic in India?

As of August 2026, the Ozempic 0.25 mg starter pen has an MRP of approximately ₹5,660. So, depending on the strength your doctor prescribes, a monthly treatment will typically cost anywhere from ₹5,660 to ₹9,100. Actual selling prices may be lower than the MRP (based on offers), so always check the latest price before purchasing.

Why did Ozempic become cheaper in 2026?

Three factors mainly contributed to lower Ozempic prices in 2026. This included its official launch in India in December 2025, Novo Nordisk's price revision in April 2026, and increased competition following the expiry of the semaglutide patent in March 2026.

Are there cheaper generic versions of semaglutide?

After the expiry of the semaglutide patent in India in March 2026, more than 26 generic semaglutide brands entered the market, with some priced from around ₹350 per week.7 They are all Schedule H prescription medicines, and their approved indications vary by brand. So, always consult your doctor before switching medicines. See our Semaglutide page for the latest brands, strengths, and prices.

Is Ozempic covered by health insurance in India?

It is usually not covered under standard health insurance policies. When Ozempic is prescribed on outpatient basis, coverage is generally available only if your policy includes OPD benefits, pharmacy cover, or chronic disease management benefits. So, always check your policy documents or contact your insurer to confirm your coverage.

Does the price mean Ozempic can be used for weight loss?

Regardless of its price, Ozempic is approved in India only for type 2 diabetes.3 Its use for weight management is an off-label decision that only a doctor can make. The semaglutide brand approved in India for chronic weight management is Wegovy.

How do I buy Ozempic online?

Consult a doctor, obtain a valid prescription, and order from a licensed pharmacy (like PharmEasy). Ozempic is a Schedule H prescription medicine and cannot be purchased over the counter. Your prescription will be verified by us before the medicine is dispensed and transported under the recommended cold-chain conditions.

References

1.PharmEasy. Ozempic pens: MRP and product listings [Internet]. Mumbai: PharmEasy; 2026 Jul [cited 2026 Jul 27]. pharmeasy.in
2.Novo Nordisk India. Ozempic (semaglutide) pricing and prescribing information: April 2026 price revision [Internet]. Bengaluru: Novo Nordisk India; 2026 Apr [cited 2026 Jul 27]. pro.novonordisk.co.in
3.Central Drugs Standard Control Organisation (CDSCO). Indian drug approval records: semaglutide (Ozempic) [Internet]. New Delhi: DGHS, Ministry of Health and Family Welfare, Government of India; 2026 [cited 2026 Jul 27]. cdscoonline.gov.in
4.Press Information Bureau (PIB). GLP-1 medicines explainer [Internet]. New Delhi: PIB, Government of India; 2026 Apr [cited 2026 Jul 27]. pib.gov.in
5.Press Information Bureau (PIB). Advisory on GLP-1 prescribing by specialists, semaglutide patent expiry, and generic entry [Internet]. New Delhi: Ministry of Health and Family Welfare, Government of India; 2026 Mar [cited 2026 Jul 27]. pib.gov.in
6.Kommu S, Whitfield P. Semaglutide. [Updated 2024 Feb 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. ncbi.nlm.nih.gov
7.Mathew J. Novo Nordisk withstands stiff generic competition post semaglutide patent expiry in India in March; 26 brands from 13 firms launched. Fortune India [Internet]. 2026 Apr 16 [cited 2026 Aug 10]. fortuneindia.com
Disclaimer

The information provided in this GLP-1 Library is intended solely to educate and inform users about GLP-1 medicines, their uses, benefits, risks, and other relevant considerations. The purpose of this content is to help users make informed decisions and have meaningful discussions with their healthcare professional. PharmEasy does not intend to promote or recommend any specific medicine, brand or treatment.

The medical and scientific aspects of the content in this GLP-1 Library have been reviewed by a qualified medical professional for medical accuracy and appropriateness. Such review is limited to the medical and scientific content and does not constitute an endorsement or recommendation of any particular medicine, drug, brand, treatment, product, or mode of drug distribution.

The information provided is for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment, and should not be considered a substitute for consultation with a qualified doctor or other healthcare professional. Before starting, stopping, or changing any medication or treatment, please consult your doctor or qualified healthcare professional. Your doctor can assess your individual health needs and determine whether a GLP-1 medicine is appropriate for you.